First gene therapy recommended for approval in the EU for TDT

TDT is a genetic disease characterised by β-globin gene mutations that cause decreased or absent haemoglobin. Credit: Gerd Altmann from Pixabay.



  • bluebird bio’s Zynteglo for TDT